Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

REPRODUCTIVE TOXICOLOGY, published by Pergamon-Elsevier Science Ltd, stands as a pivotal journal in the field of toxicology, specifically focusing on the effects of environmental and pharmaceutical agents on reproductive health. Established in 1987, the journal has a rich history of contributing to the scientific community, and it continues to publish rigorous research and reviews that illuminate the intricate relationships between various toxicants and their reproductive impacts. With an impressive 2023 Q2 ranking in Toxicology and a Scopus ranking of #42 out of 133 in the Toxicology category, REPRODUCTIVE TOXICOLOGY emphasizes high-quality scholarly work that influences both academia and industry practices. Researchers, professionals, and students in toxicology, pharmacology, and public health will find this journal an invaluable resource for staying informed on the latest findings and methodologies in reproductive toxicology. While the journal currently adheres to traditional publishing models without open access options, its authoritative content remains accessible to a global audience interested in advancing the understanding of toxicological impacts on reproduction.

THERIOGENOLOGY is a prestigious academic journal published by Elsevier Science Inc, dedicated to the field of veterinary reproduction and animal science. With an impressive impact factor and recognized as a Q1 journal in various categories including Animal Science and Zoology, Equine, Food Animals, and Small Animals, THERIOGENOLOGY has established itself as a vital resource for researchers, practitioners, and students alike. Founded in 1974, the journal covers a broad spectrum of topics related to reproductive physiology, biotechnology, and the health management of food and companion animals. Although it does not currently offer open access, researchers can benefit from its comprehensive articles and reviews that push the boundaries of knowledge in veterinary science. With a significant placement in the Scopus rankings, ranking #1 in multiple veterinary categories, THERIOGENOLOGY serves as an essential platform for advancing the understanding of reproductive strategies and practices, thereby contributing directly to the fields of animal husbandry and veterinary medicine.

Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.

Reproductive Sciences is a premier journal published by SPRINGER HEIDELBERG, dedicated to the field of obstetrics and gynecology. With its ISSN 1933-7191 and E-ISSN 1933-7205, the journal has established itself as a leading source of high-quality research and clinical insights since its inception in 2007, and continues to converge its scope into 2024. Currently ranked in the Q1 category for obstetrics and gynecology, it holds the 43rd position among 209 journals in the Scopus rankings, underscoring its influence and relevance within the medical community. This journal is particularly dedicated to advancing knowledge in reproductive health, providing a platform for innovative research and clinical practices through both traditional and open access options. Located in Switzerland with an address in Heidelberg, Germany, Reproductive Sciences is not just a publication; it is a vital resource for researchers, professionals, and students seeking to make impactful contributions to the field of reproductive health.

JOURNAL OF REPRODUCTION AND DEVELOPMENT, published by the SOCIETY REPRODUCTION & DEVELOPMENT-SRD in Japan, is a leading peer-reviewed journal dedicated to advancing the field of reproduction and development in animal sciences. With a notable impact factor reflected in its prestigious Q1 Quartile ranking in Animal Science and Zoology, the journal aims to disseminate cutting-edge research that explores the complexities of reproductive biology, developmental processes, and their implications for agriculture and biodiversity. This journal invites contributions that span multidisciplinary interests, thereby facilitating the integration of scientific knowledge and practical applications. Researchers, professionals, and students can benefit from the insights shared within its pages, as it strives to foster collaboration and innovation in the field. The journal’s comprehensive scope and esteemed reputation, underscored by its Scopus rank of #115 out of 490 in the category, make it an invaluable resource for anyone invested in the study of reproduction and development.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

Human Reproduction Open, published by Oxford University Press, is a prestigious open-access journal dedicated to advancing the field of reproductive health and medicine since its inception in 2017. With an E-ISSN of 2399-3529, the journal provides a vital platform for researchers, clinicians, and academics to disseminate innovative findings in obstetrics, gynecology, and reproductive medicine. It is recognized for its impactful contributions, holding an impressive rank of #3 out of 209 in Medicine - Obstetrics and Gynecology, #2 out of 90 in Medicine - Reproductive Medicine, and #1 out of 21 in Medicine - Embryology, placing it in the top percentiles of its respective categories. The open-access model ensures that research is freely accessible, fostering collaboration and knowledge sharing among professionals and students alike. With a commitment to high-quality, peer-reviewed publications, Human Reproduction Open plays a crucial role in shaping the future of reproductive health research and practice, serving as an essential resource for those dedicated to improving outcomes in this dynamic field.

Reproductive and Developmental Medicine is a pioneering open-access journal dedicated to advancing knowledge in the fields of reproductive medicine and developmental biology. Published by LIPPINCOTT WILLIAMS & WILKINS, the journal serves as a platform for researchers, clinicians, and graduate students alike, fostering collaboration and dissemination of innovative research findings. With an ISSN of 2096-2924 and E-ISSN 2589-8728, it has established a significant presence in the academic community since its inception in 2017. The journal is indexed in Scopus and achieved a category quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine as of 2023, highlighting its importance as a resource for cutting-edge studies and reviews in these vital areas. The journal's open-access model ensures that research is readily available to scholars and practitioners worldwide, thus enhancing the global discourse in reproductive health and development. This makes Reproductive and Developmental Medicine an invaluable resource for those dedicated to improving outcomes in obstetrics, gynecology, and reproductive health.